Interstitial vascularity in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis

EA Renzoni, DA Walsh, Michael Salmon, AU Wells, P Sestini, Alexander Nicholson, S Veeraraghavan, AE Bishop, Hanna Romanska, P Pantelidis, RM du Bois

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

The aim of this study was to evaluate interstitial vascularity in cryptogenic fibrosing alveolitis (CFA) and in fibrosing alveolitis associated with systemic sclerosis (FASSc). Open lung biopsies from eight patients with CFA, nine patients with FASSc, and normal lung from 12 patients undergoing surgery for lung cancer were studied. Markers for endothelial cells (CD34) and cell proliferation (proliferating cell nuclear antigen) were localized by sequential immunohistochemistry and quantified using computer-assisted analysis. Vascular distribution was evaluated at increasing distances (up to 160 microm) from the airspaces. Vessel density was markedly reduced in both FASSc (3.9%) and in CFA (4.5%) compared with control samples (20.4%, p <0.0001). The percentage of tissue occupied by vessels decreased with increasing distance from alveoli in control samples but not in CFA or FASSc samples. Endothelial cell proliferation indices were increased in FASSc but not in CFA, compared with control samples (p = 0.006). In conclusion, there is net vascular ablation and redistribution of blood vessels in areas of interstitial thickening in both CFA and FASSc, which may contribute to gas exchange impairment.
Original languageEnglish
Pages (from-to)438-443
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume167
DOIs
Publication statusPublished - 1 Feb 2003

Fingerprint

Dive into the research topics of 'Interstitial vascularity in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis'. Together they form a unique fingerprint.

Cite this